Kidney post-transplant monitoring of urinary glycosaminoglycans/ proteoglycans and monokine induced by IFN-γ (MIG)

Clinical and Experimental Medicine

Volumn 13, Issue 1, 2013, Pages 59-65

  De Muro, Pierina ^a   Faedda, Rossana ^a   Masala, Antonio ^a   Lepedda, Antonio Junior ^a   Zinellu, Elisabetta ^a   Ciccarese, Milco ^b   Cossu, Maria ^b   Pala, Pier Giorgio ^b   Satta, Rita Pasqualina ^b   Formato, Marilena ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b Azienda Sanitaria Locale di Sassari   (Italy)

Author keywords

Glycosaminoglycans; Kidney transplantation; Monokine induced by IFN ; Proteoglycans; Urinary trypsin inhibitor

Indexed keywords

BASILIXIMAB; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHONDROITIN SULFATE; CYCLOSPORIN; EVEROLIMUS; GAMMA INTERFERON; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MONOKINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N ACETYL BETA GLUCOSAMINIDASE; PREDNISONE; PROTEOGLYCAN; TACROLIMUS; TRYPSIN INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY ALLOGRAFT REJECTION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84873708695     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-012-0178-5     Document Type: Article

References (27)

1. Chandraker A (1999) Diagnostic techniques in the work-up of renal allograft dysfunction - an update. Curr Opin Nephrol Hypertens 8:723-728
2. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605-612
3. Opelz G (1997) Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. The Collaborative Transplant Study. Transplant Proc 29:73-76
4. Ramsden L, Rider CC (1992) Selective and differential binding of interleukin (IL)-1α, IL-1β, IL-2, and IL-6 to glycosaminoglycans. Eur J Immunol 22:3027-3031
5. Tanaka Y, Adams DH, Shaw S (1993) Proteoglycans on endothelial cells present adhesion inducing cytokines to leukocytes. Immunol Today 14:111-115
6. Calatroni A (2002) Extraction and purification of glycosaminoglycans (GAGs) from biological fluids. In: Volpi N (ed) Analytical techniques to evaluate the structure and function of natural polysaccharides, glycosaminoglycans. Research Signpost Press, Trivandrum, pp 15-22
7. Imanari T, Shinbo A, Ochiai H, Ikei T, Koshiishi I, Toyoda H (1992) Study on proteoglycans having low-sulfated chondroitin 4-sulfate in human urine and serum. J Pharmacobiodyn 15:231-237
8. Zhuo L, Salustri A, Kimata K (2003) A physiological function of serum proteoglycan bikunin: The chondroitin sulfate moiety plays a central role. Glycoconj J 19:241-247
9. Enghild JJ, Thogersen IB, Cheng F, Fransson L, Roepstorff P, Rahbek-Nielsen H (1999) Organization of the Inter-alpha-inhibitor heavy chains on the chondroitin sulfate originating from ser10 of bikunin: Posttranslational modification of I-alphaI-derived bikunin. Biochemistry 38:11804-11813
10. Mitsuhashi H, Tsukada Y, Ono K, Yano S, Naruse T (1993) Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases. Clin Nephrol 39:231-238
11. De Muro P, Faedda R, Satta A, Finetti D, Masala A, Cigni A, Sanna GM, Cherchi GM (2005) Urinary glycosaminoglycan composition in chronic glomerulonephritis. J Nephrol 18:154-160
12. De Muro P, Faedda R, Satta AE, Masala A, Cigni A, Falconi D, Sanna GM, Cherchi GM (2007) Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity. Scand J Urol Nephrol 41:230-236
13. Papaioannou EG, Magkou C, Kostakis A, Staikou C, Mitsoula P, Kyriakides S, Sitaras NM (2004) Changes in total serum glycosaminoglycan levels in patients undergoing renal transplantation: preliminary data. Surg Today 34:668-672
14. De Muro P, Faedda R, Formato M, Re F, Satta A, Cherchi GM, Carcassi A (2001) Urinary glycosaminoglycans in patients with systemic lupus erythematosus. Clin Exp Rheumatol 19:125-130
15. Yano T, Anraku S, Nakayama R, Ushijima K (2003) Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology 98:465-473
16. Inoue K, Takano H, Shimada A, Yanagisawa R, Sakurai M, Yoshino S, Sato H, Yoshikawa T (2005) Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol 67:673-680
17. Balduyck M, Mizon J (1991) Inter-alpha-trypsin inhibitor and its plasma and urine derivatives. Ann Biol Clin 49:273-281
18. Fries E, Kaczmarczyk A (2003) Inter-alpha-inhibitor, hyaluronan and inflammation. Acta Biochim Pol 50:735-742
19. Takubo T, Kuwajima S, Tatsumi N (1999) Human urinary trypsin inhibitor. Nippon Rinsho 57(Suppl):593-596
20. Groffen AJ, Veerkamp JH, Monnens LA, van den Heuvel LP (1999) Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane. Nephrol Dial Transplant 14:2119-2129
21. Moss J, Woodrow DF, Shore I, Gower P, Phillips M, Spiro RG (1990) Ultrastructural immunogold studies of heparan sulphate proteoglycan in normal human glomeruli and glomerulonephritis. J Pathol 161:137-143
22. Raats CJ, Van Den Born J, Berden JH (2000) Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria. Kidney Int 57:385-400
23. Makino H, Ikeda S, Haramoto T, Ota Z (1992) Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy. Nephron 61:415-421
24. Bradley LM, Asensio VC, Schioetz LK, Harbertson J, Krahl T, Patstone G, Woolf N, Campbell IL, Sarvetnick N (1999) Islet-specific Th1 but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J Immunol 162:2511-2520
25. Liu MT, Armstrong D, Hamilton TA, Lane TE (2001) Expression of Mig (monokine induced by interferon-γ) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol 166:1790-1795
26. Koga S, Auerbach MB, Engeman TM, Novick AC, Toma H, Fairchild RL (1999) T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFNgamma- induced chemokine Mig. J Immunol 163:4878-4885
27. Hauser IA, Spiegler S, Kiss E, Gauer S, Sichler O, Scheuermann EH, Ackermann H, Pfeilschifter JM, Geiger H, Gröne HJ, Radeke HH (2005) Prediction of acute renal allograft rejection by urinary monokine induced by IFN-γ (MIG). J Am Soc Nephrol 16:1849-1858